R

Relay Therapeutics
D

RLAY

6.02500
USD
-0.26
(-4.06%)
مغلق
حجم التداول
58,075
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
1,038,778,745
أصول ذات صلة الأخبار المقالات

العنوان: Relay Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).